Kinney Drugs is partnering with the Alzheimer's Association to present a free webinar. Attendees will learn the ten early ...

The FDA is undergoing a major transformation in its drug approval processes, regulatory oversight and transparency ...

In the third entry of Pharmacuetical Executive’s premium webinar series examining the impact of President Trump’s MFN ...

Washington health officials want to make sure you have the knowledge you need to keep your family safe when it comes to keeping medication in your home. Washington Poison Center and Forefront Suicide ...

Kinney Drugs has partnered with the Alzheimer’s Association to present a free public webinar aimed at raising awareness and ...

The complexity and heterogeneity of protein therapeutics present significant challenges in biologics discovery, as post-translational modifications (PTMs) and sequence variants can affect pr ...

Key market opportunities in dissolution testing include optimizing drug bioavailability and enhancing quality control to meet regulatory demands. Understanding scientific principles and regulatory ...

This webinar will explore polycystic kidney disease (PKD) with a focus on autosomal dominant PKD (ADPKD), including clinical presentations, considerations for conducting clinical trials in this ...

Curious about how protein crystallography fits into modern drug discovery? In this on-demand webinar, Dr. Thomas Pesnot from Concept Life Sciences chats with Dr. Debanu Das of Accelero Biostructure, ...

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

The webinar highlights market opportunities in the regulatory landscape for OTC drugs, providing professionals with key insights into FDA requirements, labeling, and compliance. This knowledge aids in ...

Experts analyze how Trump's drug pricing policies, including Most Favored Nation (MFN) and tariffs, reshape pharma markets and impact patient costs and access.